<DOC>
	<DOCNO>NCT01651481</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics safety Singulair ( 10 mg ) Xyzal ( 5 mg ) free combination fixed-dose combination HCP1102</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetics Safety Singulair Xyzal Free Combination Fixed-dose Combination</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Healthy male Age 20 55 Signed inform consent Has history hypersensitivity IP ingredient Hypotension hypertension Has history acute infection within 14 day screen</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Rhinitis</keyword>
</DOC>